Correlation, in previously treated HIV-1 positive patients, between hypersensitivity reaction to abacavir and the presence of the HLA-B*5701 allele
Correlación, en pacientes infectados por el VIH-1 y previamente tratados, entre la reacción de hipersensibilidad a abacavir y el alelo HLA-B*5701
Noemí Pérez Priora,
, Amparo Rocher Millaa, Enrique Soler Companyb, Juan Flores Cidc, Benjamín Sarria Chustd
a Servicio de Farmacia, Hospital Arnau de Vilanova, Valencia, Spain
b Departamento de Farmacología en la Universidad de Valencia, Servicio de Farmacia, Hospital Arnau de Vilanova, Valencia, Spain
c Medicina Interna-Unidad de Enfermedades Infecciosas, Hospital Arnau de Vilanova, Valencia, Spain
d Departamento de Farmacología, Universidad de Valencia, Valencia, Spain
Leído
2290
Vecesse ha leído el artículo
985
Total PDF
1305
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 85 | 35 | 120 |
| 2025 9 | 46 | 25 | 71 |
| 2025 8 | 38 | 30 | 68 |
| 2025 7 | 72 | 35 | 107 |
| 2025 6 | 33 | 17 | 50 |
| 2025 5 | 65 | 27 | 92 |
| 2025 4 | 45 | 18 | 63 |
| 2025 3 | 44 | 20 | 64 |
| 2025 2 | 43 | 27 | 70 |
| 2025 1 | 36 | 24 | 60 |
| 2024 12 | 28 | 13 | 41 |
| 2024 11 | 34 | 26 | 60 |
| 2024 10 | 37 | 16 | 53 |
| 2024 9 | 42 | 19 | 61 |
| 2024 8 | 35 | 24 | 59 |
| 2024 7 | 14 | 16 | 30 |
| 2024 6 | 31 | 10 | 41 |
| 2024 5 | 23 | 12 | 35 |
| 2024 4 | 18 | 16 | 34 |
| 2024 3 | 10 | 11 | 21 |
| 2024 2 | 26 | 18 | 44 |
| 2024 1 | 12 | 17 | 29 |
| 2023 12 | 15 | 24 | 39 |
| 2023 11 | 20 | 29 | 49 |
| 2023 10 | 19 | 18 | 37 |
| 2023 9 | 15 | 20 | 35 |
| 2023 8 | 8 | 11 | 19 |
| 2023 7 | 11 | 11 | 22 |
| 2023 6 | 18 | 12 | 30 |
| 2023 5 | 17 | 21 | 38 |
| 2023 4 | 15 | 10 | 25 |
| 2023 3 | 7 | 18 | 25 |
| 2023 2 | 13 | 12 | 25 |
| 2022 1 | 5 | 4 | 9 |
| 2022 12 | 6 | 4 | 10 |
| 2022 11 | 14 | 13 | 27 |
| 2022 10 | 7 | 5 | 12 |
| 2022 9 | 6 | 11 | 17 |
| 2022 8 | 12 | 9 | 21 |
| 2022 7 | 11 | 15 | 26 |
| 2022 6 | 16 | 8 | 24 |
| 2022 5 | 8 | 4 | 12 |
| 2022 4 | 9 | 9 | 18 |
| 2022 3 | 9 | 5 | 14 |
| 2022 2 | 5 | 3 | 8 |
| 2021 1 | 7 | 5 | 12 |
| 2021 12 | 3 | 6 | 9 |
| 2021 11 | 7 | 7 | 14 |
| 2021 10 | 5 | 9 | 14 |
| 2021 9 | 4 | 9 | 13 |
| 2021 8 | 5 | 5 | 10 |
| 2021 7 | 6 | 6 | 12 |
| 2021 6 | 4 | 4 | 8 |
| 2021 5 | 3 | 4 | 7 |
| 2021 4 | 9 | 16 | 25 |
| 2021 3 | 5 | 4 | 9 |
| 2021 2 | 5 | 4 | 9 |
| 2020 1 | 6 | 8 | 14 |
| 2020 12 | 2 | 3 | 5 |
| 2020 11 | 4 | 4 | 8 |
| 2020 10 | 4 | 1 | 5 |
| 2020 9 | 6 | 7 | 13 |
| 2020 8 | 5 | 8 | 13 |
| 2020 7 | 4 | 7 | 11 |
| 2020 6 | 3 | 3 | 6 |
| 2020 5 | 3 | 2 | 5 |
| 2020 4 | 3 | 2 | 5 |
| 2020 3 | 5 | 4 | 9 |
| 2020 2 | 1 | 2 | 3 |
| 2020 1 | 2 | 2 | 4 |
| 2019 12 | 5 | 7 | 12 |
| 2019 11 | 1 | 0 | 1 |
| 2019 10 | 1 | 1 | 2 |
| 2019 9 | 3 | 2 | 5 |
| 2019 8 | 1 | 3 | 4 |
| 2019 7 | 4 | 11 | 15 |
| 2019 6 | 10 | 9 | 19 |
| 2019 5 | 20 | 10 | 30 |
| 2019 4 | 0 | 10 | 10 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 0 | 2 | 2 |
| 2018 10 | 6 | 9 | 15 |
| 2018 9 | 3 | 5 | 8 |
| 2018 7 | 1 | 2 | 3 |
| 2018 6 | 0 | 2 | 2 |
| 2018 5 | 0 | 2 | 2 |
| 2018 4 | 1 | 1 | 2 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 0 | 1 | 1 |
| 2018 1 | 1 | 1 | 2 |
| 2017 12 | 1 | 1 | 2 |
| 2017 11 | 1 | 3 | 4 |
| 2017 10 | 2 | 2 | 4 |
| 2017 9 | 1 | 0 | 1 |
| 2017 8 | 2 | 2 | 4 |
| 2017 7 | 1 | 1 | 2 |
| 2017 6 | 7 | 0 | 7 |
| 2017 5 | 9 | 1 | 10 |
| 2017 4 | 1 | 6 | 7 |
| 2017 3 | 7 | 19 | 26 |
| 2017 2 | 2 | 1 | 3 |
| 2016 1 | 10 | 0 | 10 |
| 2016 12 | 2 | 2 | 4 |
| 2016 10 | 2 | 1 | 3 |
| 2016 9 | 2 | 0 | 2 |
| 2016 8 | 1 | 1 | 2 |
| 2016 7 | 1 | 1 | 2 |
Mostrar todo
